NCT02204579View on ClinicalTrials.gov

A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 18, 2014

Primary Completion Date

May 4, 2015

Study Completion Date

May 4, 2015

Conditions
Autosomal Dominant Hypocalcemia (ADH)
Interventions
DRUG

NPSP795

Trial Locations (1)

20892-1103

National Institute of Health (NIH), Bethesda

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Shire

INDUSTRY

NCT02204579 - A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations | Biotech Hunter | Biotech Hunter